期刊文献+

关注多囊卵巢综合征与胰岛素抵抗 被引量:1

Polycystic ovary syndrome (PCOS) and insulin resistance
下载PDF
导出
摘要 多囊卵巢综合征(PCOS)患者无论是否肥胖,均存在胰岛素抵抗(IR),可表现为高胰岛素血症和糖代谢异常。PCOS患者不仅存在IR,而且有胰岛β细胞功能障碍。PCOS患者IR的发生与胰岛素受体后信号通道缺陷有关。治疗措施包括改善不良的生活方式、减轻体重、二甲双胍等。 Regardless of obesity or not, patients with polycystic ovary syndrome (PCOS) might have profound insulin resistance (IR), which may lead to hyperinsulinemia and glucose metabolism abnormality. PCOS is not only associated with IR, but also with defects in pancreatic β-cell function. IR in PCOS in due to post-insulin receptor defects in insulin signaling. Treatments include lifestyle modification, weight loss, metformin and so on.
作者 李启富
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2007年第2期65-66,共2页 Chinese Journal of Diabetes
关键词 多囊卵巢综合征 胰岛素抵抗 受体 胰岛素 二甲双胍 Polycystic ovary syndromel Insulin resistancel Receptor, insulinl Metformin
  • 相关文献

参考文献7

  • 1李昕,林金芳.肥胖型多囊卵巢综合征患者临床及内分泌代谢特征的研究[J].中华医学杂志,2005,85(46):3266-3271. 被引量:137
  • 2Dunaif A,Insulin resistance in women with polycystic ovary syndrome.Fertil Steril,2006,86(Supp1):S13-S14.
  • 3Legro RS.Type 2 diabetes and polycystic ovary syndrome.Fertil Steril,2006,86(Suppl):S16-S17.
  • 4Ehrmann DA,Kasza K,Azziz R,et al.Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome.J Clin Endocrinol Metab,2005,90:66-71.
  • 5Legro RS,Gnatuk CL,Kunselman AR,et al.Changes in glucose tolerance over time in women with polycystic ovary syndrome:a controlled study.J Clin Endocrinol Metab,2005,90:3236-3242.
  • 6Ovalle F and Azziz R.Insulin resistance,polycystic ovary syndrome,and type 2 diabetes mellitus.Fertil Steril,2002,77:1095-1105.
  • 7Lobo RA.Choice of treatment for women with polycystic ovary syndrome.Fertil Steril,2006,86(Supp1):S22-S23.

二级参考文献17

  • 1Pantanetti P, Garrapa GG, Mantero F, et al. Adipose tissue as an endocrine organ? A review of recent data related to cardiovascular complications of endocrine dysfunctions. Clin Exp Hypertens,2004,26:387-398.
  • 2Diamanti-Kandarakis E, BergieleA. The influence of obesity on hyperandrogenism and infertility in the female. Obesity Reviews ,2001, 2:231-238.
  • 3Ciampelli M , Leoni F , Lattanzi F , et al. A pilot study of the long 2 term effects of acipimox in polycystic ovarian syndrome. Hum Reprod, 2002 ,17:647-653.
  • 4Marsden PJ , Murdoch AP , Taylor R. Tissue insulin sensitivity and body weight in polycystic ovary syndrome. Clin Endocrinol , 2001 ,55:191-199.
  • 5Dunaif A. Insulin resistance and the polycystic ovary syndrome:mechanism and implications for pathogenesis. Endocr Rev, 1997,18 : 774 - 800.
  • 6Barzilai N, Wang J, Massilon D, et al. Leptin selesctively decreases visceral adiposity and enhances insulin action. J Clin Invest, 1997,100:3105-3110.
  • 7Farah L, Lazenby A J, Boots LR, et al. Prevalence of polycystic ovary syndrome in women seeking treatment from community electrologists(Alabama Professional Electrology Association Study Group ). J Reprod Med, 1999,44:870-974.
  • 8Diamanti-Kandarakis E, Kouli CR, Bergiele AT ,et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbost hormonal and metabolic profile. J Clin Endocrinol Metab, 1999, 84: 4006-4011.
  • 9Gambineril A, Pelusil C, Vicennatil V, et al. Obesity and the polycystic ovary syndrome. Int J Obesity, 2002,26:883-896.
  • 10Pasquali R, Casimirri F. The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women. Clin Endocrinol, 1993,39: 1-16.

共引文献136

同被引文献18

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部